Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Pancreatic Neoplasms × Digoxin × Clear all

Phase

Status

Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Pancreatic Neoplasms 1 Leiomyosarcoma 1

Interventions

Gemcitabine 56 130-nm albumin-bound paclitaxel 28 Specimen Handling 18 Magnetic Resonance Spectroscopy 18 Taxes 17 Albumin-Bound Paclitaxel 17 Leucovorin 16 Fluorouracil 16 pembrolizumab 15 Oxaliplatin 15 Drug Therapy 14 Irinotecan 12 Cyclophosphamide 11 Biopsy 11 fludarabine 10 Blood Specimen Collection 10 olaparib 7 irinotecan sucrosofate 7 folfirinox 6 Cetuximab 6 Capecitabine 6 dehydroftorafur 5 Radiotherapy 5 Radiosurgery 5 Magnetic Resonance Imaging 5 Cisplatin 5 Bevacizumab 5 sintilimab 4 durvalumab 4 camrelizumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06030622 2024-04-19

C3

State University of New York - Downstate Medical Center

Phase 1/2 Recruiting

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡